New personalized vaccine aims to control advanced colon and pancreatic cancer
NCT ID NCT07587827
First seen Jun 01, 2026 · Last updated Jun 17, 2026 · Updated 3 times
Summary
This early-phase trial tests a personalized vaccine (ODI-2001) for people with advanced colon or pancreatic cancer that has spread or cannot be removed. The vaccine is custom-made to target each patient's unique tumor mutations. The study first checks safety and the right dose, then looks at how well it controls cancer growth. About 77 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU Jean Minjoz
Besançon, 25000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Georges-François Leclerc
Dijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.